tradingkey.logo

tradingkey.logo
怜玢


IDEXX Laboratories Inc

IDXX
りォッチリストに远加
560.110USD
-12.090-2.11%
終倀 05/08, 16:00ET15分遅れの株䟡
44.18B時䟡総額
40.93盎近12ヶ月PER


IDEXX Laboratories Inc

560.110
-12.090-2.11%

詳现情報 IDEXX Laboratories Inc 䌁業名

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX Laboratories Incの䌁業情報


䌁業コヌドIDXX
䌚瀟名IDEXX Laboratories Inc
䞊堎日Jun 21, 1991
最高経営責任者「CEO」Emerson (Andrew)
埓業員数11000
蚌刞皮類Ordinary Share
決算期末Jun 21
本瀟所圚地One Idexx Drive
郜垂WESTBROOK
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号04092-2041
電話番号12075560300
りェブサむトhttps://www.idexx.com/
䌁業コヌドIDXX
䞊堎日Jun 21, 1991
最高経営責任者「CEO」Emerson (Andrew)

IDEXX Laboratories Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
8.25K
-3.84%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
--
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.17K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.16K
-0.46%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.10K
+3.00%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
3.00K
+36.06%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Ms. Irene Chang Britt
Ms. Irene Chang Britt
Independent Director
Independent Director
208.00
--
Ms. Karen Peacock
Ms. Karen Peacock
Independent Director
Independent Director
1.00
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
8.25K
-3.84%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
--
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.17K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.16K
-0.46%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.10K
+3.00%

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
䌚瀟名
収益
比率
CAG Diagnostics recurring revenue
3.41B
79.17%
IDEXX VetLab consumables
1.50B
34.78%
Reference laboratory diagnostic and consulting services
1.42B
33.09%
Rapid assay products
348.95M
8.11%
CAG Diagnostics capital - instruments
345.88M
8.04%
他の
-2.72B
-63.18%
地域別USD
䌚瀟名
収益
比率
United States
2.75B
63.96%
Other Euorpe
230.03M
5.34%
Germany
206.76M
4.80%
Canada
167.32M
3.89%
United Kingdom
154.44M
3.59%
他の
792.37M
18.41%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
CAG Diagnostics recurring revenue
3.41B
79.17%
IDEXX VetLab consumables
1.50B
34.78%
Reference laboratory diagnostic and consulting services
1.42B
33.09%
Rapid assay products
348.95M
8.11%
CAG Diagnostics capital - instruments
345.88M
8.04%
他の
-2.72B
-63.18%

株䞻

曎新時刻: 7 hours ago
曎新時刻: 7 hours ago
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
BlackRock Institutional Trust Company, N.A.
6.79%
Vanguard Capital Management, LLC
6.57%
Vanguard Portfolio Management, LLC
4.96%
State Street Investment Management (US)
4.64%
Geode Capital Management, L.L.C.
3.28%
他の
73.77%
株䞻統蚈
株䞻統蚈
比率
BlackRock Institutional Trust Company, N.A.
6.79%
Vanguard Capital Management, LLC
6.57%
Vanguard Portfolio Management, LLC
4.96%
State Street Investment Management (US)
4.64%
Geode Capital Management, L.L.C.
3.28%
他の
73.77%
皮類
株䞻統蚈
比率
Investment Advisor
54.08%
Investment Advisor/Hedge Fund
31.62%
Research Firm
3.69%
Pension Fund
3.67%
Bank and Trust
1.77%
Hedge Fund
0.74%
Individual Investor
0.70%
Sovereign Wealth Fund
0.69%
Family Office
0.48%
他の
2.56%

機関投資家保有株


曎新時刻: Sun, Apr 5
曎新時刻: Sun, Apr 5
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
2458
76.16M
96.54%
-2.09M
2025Q4
2411
81.21M
101.70%
-691.60K
2025Q3
2319
77.76M
97.19%
-4.03M
2025Q2
2277
79.81M
99.73%
-1.01M
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
BlackRock Institutional Trust Company, N.A.
5.36M
6.74%
+116.07K
+2.22%
Dec 31, 2025
State Street Investment Management (US)
3.66M
4.6%
+138.96K
+3.95%
Dec 31, 2025
Geode Capital Management, L.L.C.
2.58M
3.25%
+86.26K
+3.45%
Dec 31, 2025
Fundsmith LLP
1.88M
2.36%
-734.42K
-28.13%
Dec 31, 2025
Baron Capital Management, Inc.
1.80M
2.26%
-86.09K
-4.57%
Dec 31, 2025
Invesco Capital Management (QQQ Trust)
1.70M
2.14%
-41.26K
-2.37%
Feb 28, 2026
BlackRock Asset Management Ireland Limited
996.39K
1.25%
-2.29K
-0.23%
Dec 31, 2025
Polen Capital Management, LLC
960.54K
1.21%
-166.61K
-14.78%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Tue, Dec 2
曎新時刻: Tue, Dec 2
銘柄名
比率
ProShares Pet Care ETF
9.4%
iShares U.S. Medical Devices ETF
4.42%
First Trust Water ETF
3.98%
SMI 3Fourteen Full-Cycle Trend ETF
3.9%
Nuveen ESG Mid-Cap Growth ETF
3.47%
Adaptive Core ETF
2.61%
First Trust S&P 500 Economic Moat Index ETF
2.25%
Acruence Active Hedge US Equity ETF
2.18%
Tema Durable Quality ETF
2.1%
Putnam Sustainable Future ETF
2.03%
詳现を芋る
ProShares Pet Care ETF
比率9.4%
iShares U.S. Medical Devices ETF
比率4.42%
First Trust Water ETF
比率3.98%
SMI 3Fourteen Full-Cycle Trend ETF
比率3.9%
Nuveen ESG Mid-Cap Growth ETF
比率3.47%
Adaptive Core ETF
比率2.61%
First Trust S&P 500 Economic Moat Index ETF
比率2.25%
Acruence Active Hedge US Equity ETF
比率2.18%
Tema Durable Quality ETF
比率2.1%
Putnam Sustainable Future ETF
比率2.03%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™